Untitled Document
sitemap enquiry contact  
Our R&D is set to facilitate the development of pharmaceutical formulations and to cater to the needs of the global clientele of Bafna Pharma. Inaugurated at the hands of Shri Mike Nithavrianakis, British Deputy High Commissioner to Southern India, the R&D facility, is a state-of-art facility for formulation development and analytical development and is designed and equipped to meet the stringent international standards. This new facility is in complete compliance with cGMP, cGLP & ICH guidelines in conducting the R&D activities along with full regulatory compliance to EU-DMF and US-DMF.
With advanced R&D equipments, testing instruments and process control facilities, the R&D center is equipped to manufacture new products from laboratory scale to validation batches. The R&D center has qualified and competent research scientists, who have developed many innovations in the manufacture of formulations, to meet the various requirements of the global market. We strongly believe that with the launch of the new R&D centre we will significantly elevate our efforts in enhancing and developing new products and exceed our customer expectations.
The R&D facility has in-depth exposure to literature search, patent search and preparation of pre-formulation Studies; to conduct analysis on new prototype formulations and to check the feasibility of the product; Development and Optimization of Formula; process improvement; Preparation of Stability batches; Accelerated stability studies and many more intricacies in the formulation development. The overall operations by the R&D will have a direct impact on the commercial manufacturing batches, costing and in providing utmost satisfaction to Bafna Pharma’s customers worldwide.
Through this facility, Bafna will file dossiers for the ever growing, US, UK, Australia and the European Markets and ever emerging RoW markets. This facility will offer a one-stop solution right from development to formulation to dossier making to commercial production and in the long run, the facility is going to be a completely independent profit-making center. The overall objective of this facility is to develop the pharmaceutical products on Contract basis and to design and develop the products indigenously for the ever-expanding Pharma market. This facility will propel to the realization of our mission of achieving INR 5000 million by 2013.
Highlights of our R&D facility
Perfect organogram & lab setup.
Highly-skilled professional scientists.
Strong analytical team support.
R&D QA for systems & Documentation.
Formulation Development - New Project.
Process Development and Process Optimization.
Perfect organogram & lab setup.
Analytical Method Development and Method Validation.
Analytical Method Transfer.
Stability Study as Per ICH Guidelines.
Key Instruments In Our R & D
Fluidised Bed Processor 5lts.
Retsch Drier (1kg).
RMG ( Rapid Mix Granulator) 2,5,10lts.
Bin blender 2,5,10, 50lts.
Compression Machine 5 station, B tooling and 5 station D tooling.
Coating Machine 0.5kg.
Blister, Alu / Alu Semi Automatic Packing Machine.
Analytical Method Development and Method Validation.
arrow more
Udyog Rattan Award
Our Chairman & Managing Director Mr. Bafna Mahaveer Chand, has received "Udyog Rattan Award".
IDMA Award
Received IDMA Quality Excellence Silver Award 2010 – in the category of Formulation Units.
Bafna Pharma
icon Profile
icon CEO Statement
icon Vision & Mission
icon Board of Directors
icon Management Profile
icon Accreditations & Awards
icon Life at Bafna
icon Domestic Marketing
icon International Marketing
icon International Export
icon Business Development
icon Quality Policies
icon Facility ‑ Madhavaram
icon Facility ‑ Grantlyon
icon R & D
icon Visual Gallery
icon Financials
icon Presentations
icon FAQ
icon Stock Price
icon Share Holding Pattern
icon Disclosure
icon Policies
icon Domestic
icon Exports
icon Press Release
icon Bafna in the news
icon Job openings
icon Apply now
icon Health Sense
icon Environment
icon Responsibility
mailus separator


sepearator sepearator sepearator sepearator
chat   facebook   twitter